Browsing Centre for Biochemical Pharmacology by Author "FitzGerald, JM"
Now showing items 1-8 of 8
-
Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma Registry.
Scelo, G; Torres-Duque, CA; Maspero, J; Tran, TN; Murray, R; Martin, N; Menzies-Gow, AN; Hew, M; Peters, MJ; Gibson, PG (2023-08-26)BACKGROUND: Investigation for the presence of asthma comorbidities is recommended by GINA as their presence can complicate asthma management. OBJECTIVE: To understand the prevalence and pattern of comorbidities and ... -
Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe Asthma.
Wechsler, ME; Scelo, G; Larenas-Linnemann, DES; Torres-Duque, CA; Maspero, J; Tran, TN; Murray, RB; Martin, N; Menzies-Gow, AN; Hew, M (2023-11-28)RATIONALE: Previous studies investigating comorbidity impact on biologic effectiveness have been relatively small, of short duration, and have not compared biologic classes. OBJECTIVES: To determine the association between ... -
Comparative effectiveness of Anti-IL5 and Anti-IgE biologic classes in patients with severe asthma eligible for both
Pfeffer, PE; Ali, N; Murray, R; Ulrik., C; Tran, TN; Maspero, J; Peters, M; Christoff, GC; Sadatsafavi, M; Torres-Duque, CA (2023) -
Eosinophilic and non-eosinophilic asthma: an expert consensus framework to characterize phenotypes in a global real-life severe asthma cohort.
Heaney, LG; Perez de Llano, L; Al-Ahmad, M; Backer, V; Busby, J; Canonica, GW; Christoff, GC; Cosio, BG; FitzGerald, JM; Heffler, E (2021-04-19)BACKGROUND: Phenotypic characteristics of eosinophilic and non-eosinophilic asthma patients are not well-characterized in global, real life severe asthma cohorts. RESEARCH QUESTION: What is the prevalence of eosinophilic ... -
Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry.
Chen, W; Tran, TN; Sadatsafavi, M; Murray, R; Wong, NCB; Ali, N; Ariti, C; Bulathsinhala, L; Gil, EG; FitzGerald, JM (2023-09)BACKGROUND: Effectiveness of biologics has neither been established in patients with high oral corticosteroid exposure (HOCS) nor been compared with effectiveness of continuing with HOCS alone. OBJECTIVE: To examine the ... -
International severe asthma registry (ISAR): protocol for a global registry
FitzGerald, JM; Tran, TN; Alacqua, M; Altraja, A; Backer, V; Bjermer, L; Bjornsdottir, U; Bourdin, A; Brusselle, G; Bulathsinhala, L (BioMed Central, 2020-08-14) -
Prevalence of Comorbidities in Adults with Severe Asthma: Results from the International Severe Asthma Registry (ISAR)
Scelo, G; Porsbjerg, CM; Carter, V; Ariti, C; Lyu, J; Eleangovan, N; Tran, TN; Barker, P; Katial, R; Martin, N (2022) -
Reply to "Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry".
Chen, W; Tran, TN; Sadatsafavi, M; Murray, RB; Boon Wong, NC; Ali, N; Ariti, C; Bulathsinhala, L; Garcia Gil, E; FitzGerald, JM (2024-02)